STAR 
Strides Arcolab Ltd
How do you think star will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 16
![]()
16 outperforms
0 underperforms
Stars: Top Investors who have picked this stock: 3
![]()
3 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 532531 / STAR
- Last traded time
- 2012-05-24 13:07:40
- Last traded on
- NSE
- Intra-day Low / High
- 672.1 / 692.0
- 52w closing Low / High
- 280.5 / 697.7
- Today Volume
- 41,344
- 30d avg Daily Volume
- 253,318
- Market Cap
- INR 4,028.6 cr
- P/E Ratio TTM
- 62.25
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -1.1%
- 0.0%
- 2.7%
- 25.6%
- 82.7%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks
| Jan-2012 | Feb-2012 | Mar-2012 | Apr-2012 | % of Assets | Asset Value | |
|---|---|---|---|---|---|---|
| MUTUAL FUND GROUP | Number of Shares | % | (Rs. cr) | |||
| CUMULATIVE | - | - | - | - | -- | - |
++ Number of shares are either disclosed by AMC on a monthly basis OR calculated based on disclosed asset value and month-end closing stock price.
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
STAR IN THE NEWS
- Apr-27 11:00 Strides Arcolab's director resigns
- Apr-27 8:01 Strides Arcolab reports net loss of Rs 28.16 crore in the March 2012 quarter
- Apr-19 14:33 Strides Arcolab receives USFDA approval for Cisplatin Injection
- Apr-19 9:18 Strides Arcolab allots equity shares
- Apr-18 12:09 Strides Arcolab to announce financial results
- Apr-11 12:05 Strides Arcolab receives USFDA approval for Vancomycin Oral Capsules
- Mar-20 11:44 Strides Arcolab allots equity shares
- Mar-13 10:13 Strides Arcolab allots equity shares
- Mar-02 17:12 Strides Arcolab allots equity shares
- Feb-27 15:43 Strides Arcolab net profit rises 134.49% in the December 2011 quarter
TOP BLOGS
- The business of Indian politics
by AJAY SHAH
(Recommendations: 7) - Mid Week Update
by Nishit_Vadhavkar
(Recommendations: 5) - Advice for – Thursday, May 24, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - At last the Government bites the bullet
by ASHOKSHARMA
(Recommendations: 8) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |
